William Joseph Drazkowski - 02 Jan 2024 Form 4/A Insider Report for FASTENAL CO (FAST)

Reporting relationship: EXECUTIVE VICE-PRESIDENT
Issuer ticker: FAST
Reported as of: 02 Jan 2024
Net transaction value: $0
SEC form: 4/A
Accepted by SEC: 04 Jan 2024, 15:10:46 UTC
Original report date: 04 Jan 2024
Prior SEC filing: 14 Dec 2023
Next SEC filing: 29 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ John J Milek, Attorney-in-Fact

Filing notes and source

Key filing fact

William Joseph Drazkowski filed Form 4/A for FASTENAL CO (FAST) on 04 Jan 2024.

Key facts

This page summarizes William Joseph Drazkowski's Form 4/A filing for FASTENAL CO (FAST).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Jan 2024, 15:10.

Change

Previous filing in this sequence was filed on 14 Dec 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FAST transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +18,281
Change %
Price: $0.000000
Shares after: 18,281
Date: 02 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,281
Exercise price: $64.00
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The amount of 19,500 was incorrectly reported in a filing on January 4, 2024 due to an administrative error. This amendment is filed to identify the correct amount of 18,281 derivative securities acquired with this transaction.

Footnote F2

The option will fully vest and become exercisable over a period of five years, with 20% vesting and becoming exercisable each year following the grant date.